![Andrew Kay](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Andrew Kay
Vorsitzender bei
NUCANA PLC
Vermögen: - $ am 31.03.2024
Profil
Andrew Martin Kay is currently Chairman at NuCana Plc since 2020, Non-Executive Chairman at Ember Ltd., Chairman at Amulet Consulting Ltd. since 2014, Director at NeRRe Therapeutics Holdings Ltd. since 2017, and Director at Chaperhome Ltd. since 2021.
Former roles include President & Chief Executive Officer at Algeta ASA from 2009 to 2014, Chairman at Wilson Therapeutics AB from 2015 to 2018, Chairman at Blueberry Therapeutics Ltd. from 2015 to 2023, Chairman at KaNDy Therapeutics Ltd. from 2019 to 2020, Chairman at NeRRe Therapeutics Ltd. from 2017 to 2026, Executive Director-Commercial at Ultimate Finance Holdings Ltd. in 2008, Executive Director-Commercial at Renovo Ltd., and Global Head-Marketing & Sales at Novartis UK Ltd. from 1999 to 2003.
Education includes an undergraduate degree from the School of Pharmacy.
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
NUCANA PLC -.--% | 18.03.2026 | 0 ( -.--% ) | - $ | 31.03.2024 |
Aktive Positionen von Andrew Kay
| Unternehmen | Position | Beginn |
|---|---|---|
| NUCANA PLC | Vorsitzender | 21.12.2020 |
Ember Ltd. | Vorsitzender | - |
Amulet Consulting Ltd. | Vorsitzender | - |
NeRRe Therapeutics Holdings Ltd.
 NeRRe Therapeutics Holdings Ltd. Miscellaneous Commercial ServicesCommercial Services Engages in research and development of biotechnology | Direktor/Vorstandsmitglied | 15.09.2017 |
Chaperhome Ltd.
 Chaperhome Ltd. Packaged SoftwareTechnology Services Develops walk-safe applications | Direktor/Vorstandsmitglied | 18.02.2021 |
Ehemalige bekannte Positionen von Andrew Kay
| Unternehmen | Position | Ende |
|---|---|---|
NeRRe Therapeutics Ltd.
 NeRRe Therapeutics Ltd. Medical DistributorsDistribution Services Provides clinical and pre clinical drugs for treatment of neuronal hypersensitivity | Vorsitzender | 01.01.2026 |
Blueberry Therapeutics Ltd.
 Blueberry Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology Engages in drug research and development | Vorsitzender | 13.10.2023 |
KaNDy Therapeutics Ltd.
 KaNDy Therapeutics Ltd. BiotechnologyHealth Technology Develops medicines for female sex hormone disorders | Vorsitzender | 01.09.2020 |
| WILSON THERAPEUTICS AB | Vorsitzender | 01.06.2018 |
| ░░░░░░ ░░░ | ░░░░░░░░░░░░░░░░░░░░░ | ░░░░░░░░░░ |
Ausbildung von Andrew Kay
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
36
Beziehungen ersten Grades
14
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 14 |
|---|---|
Ultimate Finance Holdings Ltd.
 Ultimate Finance Holdings Ltd. Finance/Rental/LeasingFinance Operates as a holding company with interest in provides business financing services | Finance |
Renovo Ltd.
 Renovo Ltd. Pharmaceuticals: MajorHealth Technology Manufactures and distributes pharmaceutical products | Health Technology |
Algeta ASA
 Algeta ASA Pharmaceuticals: MajorHealth Technology Engages in the development of products for the treatment of cancer | Health Technology |
Novartis UK Ltd.
 Novartis UK Ltd. Pharmaceuticals: MajorHealth Technology Manufactures and markets general medicines and pharmaceutical products | Health Technology |
NuCana Plc
 NuCana Plc BiotechnologyHealth Technology Develops and commercializes novel anti-cancer medicines | Health Technology |
Ember Ltd. | |
NeRRe Therapeutics Ltd.
NeRRe Therapeutics Ltd. Medical DistributorsDistribution Services Provides clinical and pre clinical drugs for treatment of neuronal hypersensitivity | Distribution Services |
Wilson Therapeutics AB
 Wilson Therapeutics AB Pharmaceuticals: MajorHealth Technology Operates as biopharmaceutical company focusing in treatment of Wilson disease | Health Technology |
School of Pharmacy
 School of Pharmacy Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Blueberry Therapeutics Ltd.
Blueberry Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology Engages in drug research and development | Health Technology |
Amulet Consulting Ltd. | |
KaNDy Therapeutics Ltd.
KaNDy Therapeutics Ltd. BiotechnologyHealth Technology Develops medicines for female sex hormone disorders | Health Technology |
NeRRe Therapeutics Holdings Ltd.
NeRRe Therapeutics Holdings Ltd. Miscellaneous Commercial ServicesCommercial Services Engages in research and development of biotechnology | Commercial Services |
Chaperhome Ltd.
Chaperhome Ltd. Packaged SoftwareTechnology Services Develops walk-safe applications | Technology Services |
